Agios Pharma (AGIO) Reports In-Line Q1 EPS

Agios Pharma (NASDAQ: AGIO) reported Q1 EPS of ($1.63), in-line with the analyst estimate of ($1.63). Revenue for the quarter came in at $8.76 million versus the consensus estimate of $10.6 million.

For earnings history and earnings-related data on Agios Pharma (AGIO) click here.

You May Also Be Interested In

• onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
• Darden Restaurants (DRI) Tops Q4 EPS by 3c, Misses on Revenue; Offers FY27 Guidance
• MakeMyTrip (MMYT) PT Raised to $84 at Goldman Sachs